States urged to register compounding pharmacies

The federal government has sent letters to states and other stakeholders across the country calling on them to encourage compounding pharmacies to register as a producer of sterile drugs in an effort to protect the public.

The letter from the Food and Drug Administration is dated Wednesday. It reminds of last year's law passed in response to a from contaminated injections that killed 64 people and sickened more than 750. The outbreak has been traced to the now-closed New England Compounding Center pharmacy in Framingham.

Iowa U.S. Sen. Tom Harkin said Friday that the law and the FDA's letter help "ensure the safety of compounded drugs and is aimed at helping to prevent a future public health crisis."

Registering with the FDA is voluntary under the law.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA starts regulating compounding pharmacies

Dec 02, 2013

(HealthDay)—The U.S. Food and Drug Administration on Monday began the process of regulating compounding pharmacies, which create new drug combinations or alter drugs to suit individual patient needs.

Bulk mixers of prescribed drugs get more scrutiny

Nov 18, 2013

Congress has taken a half step toward increasing federal oversight of so-called compounding pharmacies that custom mix medications in bulk, a year after a meningitis outbreak from contaminated pain injections killed at least ...

Consumer watchdog asks FDA to revisit compounders

Nov 29, 2012

(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded ...

FDA chief renews push for specialty pharmacy rules

Dec 19, 2012

(AP)—The head of the Food and Drug Administration renewed her push for new rules to help police pharmacies like the one that triggered a deadly meningitis outbreak, even as members of Congress expressed little interest ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

9 hours ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments